The invention relates to the production and use of novel 14β-alkyl-18-norsteroids, 8α,14β-dialkyl-18-norsteroids, spiro[cyclopentano-perhydronaphthalin]-3,1′-pentanes or hexanes in addition to 14β-fluoro-15β,17β-dihydroxy-steroids, by reacting 17-hydroxy-14,15-epoxi-steroids with water-free acids or Lewis acids and followed by derivatisation. The resulting compounds can be used as intermediate products for or as medicaments in human and veterinary medicine, whereby the emphasis is on improving inflammatory processes, hormone replacement therapy and the use thereof as enzyme inhibitors in the treatment of tumours.
本发明涉及新型 14β-烷基-18-正甾烷、8α,14β-二烷基-18-正甾烷、螺[
环戊烷-过氢
萘]-3,1′-
戊烷或己烷以及 14β-
氟-15β,17β-二羟基-类
固醇的生产和使用,其方法是将 17-羟基-14,15-环氧类
固醇与无
水酸或
路易斯酸反应,然后进行衍生化。由此产生的化合物可用作人类和兽类医药的中间产品或药物,重点是改善炎症过程、激素替代疗法以及将其用作治疗肿瘤的酶
抑制剂。